The Effect of Web-based Education on Gynecological Cancer Awareness and Healthy Life Behaviors

June 3, 2025 updated by: DERYA YÜKSELEN EROL, Inonu University

The Effect of Web-based Gynecological Cancer Awareness on Married Women's Gynecological Cancer Awareness and Healthy Lifestyle Behaviors

There are cross-sectional or quasi-experimental studies in the literature on gynecological cancer awareness, but there are no fully experimental studies. The study we will conduct will use a control group and will be a fully experimental study. Thus, it is thought to contribute more to the field. The purpose of the study is to determine the effect of gynecological cancer education given to married women on their gynecological cancer awareness and healthy living behaviors.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

The aim of the study was to determine the effect of web-based gynecological cancer education on gynecological cancer awareness and healthy life behaviors of married women. For this purpose, participants were divided into two groups and web-based education was given to the experimental group.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Malatya, Turkey, 44000
        • Family Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being between the ages of 20-65
  • Being open to communication
  • Being literate
  • Being able to use the internet
  • Having a smart phone or computer

Exclusion Criteria:

  • Being pregnant
  • Being breastfeeding
  • Not being able to use a website
  • Not having watched all the videos on the website
  • Having a history of gynecological cancer in oneself or in one's family

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Web based training
Web-based training will be given to experimental group and the results of the training will be evaluated
Behavioral: Web based training
This group will receive information about healthy lifestyle behaviors and gynecological cancer awareness.
No Intervention: control group
Participants in this group will not be provided with training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gynecological cancer awareness scale
Time Frame: 4 weeks
Preliminary test results received. The minimum score that can be obtained from the scale is 41, the maximum score is 205. The pre-training scale score average of the experimental group is 90.97.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Inonu University

Investigators

  • Study Director: Yurdagül Y Yağmur, Inonu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2025

Primary Completion (Estimated)

June 5, 2025

Study Completion (Estimated)

June 7, 2025

Study Registration Dates

First Submitted

May 25, 2025

First Submitted That Met QC Criteria

June 3, 2025

First Posted (Actual)

June 6, 2025

Study Record Updates

Last Update Posted (Actual)

June 6, 2025

Last Update Submitted That Met QC Criteria

June 3, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • DYUKSELENEROL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Scale results will be shared.

IPD Sharing Time Frame

It will be accessible in March 2025. It will be accessible for 6 months.

IPD Sharing Access Criteria

Those working in the field of nursing will be able to access it.

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Women

Clinical Trials on Web based training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe